Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jul 1;160(1):310-6.
doi: 10.1084/jem.160.1.310.

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

C Huber et al. J Exp Med. .

Abstract

Neopterin, a compound derived from GTP, represents a precursor molecule of biopterin that is an essential cofactor in neurotransmitter synthesis. We have recently reported that in vivo as well as in vitro immune responses are accompanied by an increased release of neopterin and that this phenomenon can be used for the biochemical monitoring of diseases accompanied by hyperimmune stimulation. This article deals with the cellular origin and the control of this immune response-associated neopterin release in vitro. Using highly purified or monoclonal cellular reagents we demonstrate that macrophages (M phi) stimulated with supernatants from activated T cells release large amounts of neopterin into culture supernatants. Further experiments involving induction of neopterin release from M phi with various human recombinant interferons (IFNs) or neutralization of the effect of T cell supernatants with various monoclonal anti-IFN antibodies revealed immune IFN as the active principle. It thus appears that a metabolic pathway so far exclusively known in context with the generation of an essential cofactor of neurotransmitter-synthesis during immune responses is also activated in M phi under stringent control by immune IFN-like lymphokines.

PubMed Disclaimer

References

    1. Hoppe Seylers Z Physiol Chem. 1979 Dec;360(12):1957-60 - PubMed
    1. J Immunol. 1981 Aug;127(2):726-31 - PubMed
    1. J Exp Med. 1982 Apr 1;155(4):1222-7 - PubMed
    1. Science. 1982 Apr 23;216(4544):429-31 - PubMed
    1. J Infect Dis. 1982 Oct;146(4):451-9 - PubMed

Publication types